Ver mas grande
B3GNT5 antibody
FT-FNab00769
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | B3GNT5 |
| Research Area | Metabolism, Developmental biology |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase|Lactotriaosylceramide synthase (Lc(3)Cer synthase, Lc3 synthase)|UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5 (BGnT-5, Beta-1,3-Gn-T5, Beta-1,3-N-acetylglucosaminyltransferase |
| Host | Rabbit |
| UniProt ID | Q9BYG0 |
| Gene ID | 84002 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 44kd |
| Background | Beta-1,3-N-acetylglucosaminyltransferase that plays a key role in the synthesis of lacto-or neolacto-series carbohydrate chains on glycolipids, notably by participating in biosynthesis of HNK-1 and Lewis X carbohydrate structures. Has strong activity towa |
Más información
B3GNT5 antibody